US Patent 11963990 Oncolytic viruses for modified MHC expression
Patent 11963990 was granted and assigned to KalIvir Immunotherapeutics on April, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11963990 Oncolytic viruses for modified MHC expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
